Changes of skeletal muscle in young dystrophin-deficient cats: A morphological and morphometric study

被引:0
|
作者
Gaschen F. [1 ]
Burgunder J.-M. [2 ]
机构
[1] Division of Small Animal Medicine, Dept. Clinical Veterinary Medicine, Faculty of Veterinary Medicine, 3012 Bern
[2] Neuromorphological Laboratory, Department of Neurology, Faculty of Medicine, University of Bern
关键词
Duchenne muscular dystropy; Dystrophin deficiency; Histology; Hypertrophic feline muscular dystropy; Morphology;
D O I
10.1007/s004010000299
中图分类号
学科分类号
摘要
Dystrophin deficiency causes Duchenne muscular dystrophy (DMD). Hypertrophic feline muscular dystrophy (HFMD) is a homologous animal model of DMD. Our objective was to investigate the early changes caused by dystrophin deficiency in skeletal muscle of cats of 3-4 and 6-9 months. Obvious histological lesions were already present in the younger cats, and they increased in magnitude over time. They consisted of multifocal areas of degeneration and regeneration with mononuclear infiltration, and a wide variation in myofiber diameter, as evidenced by significantly increased variability coefficients in muscle fiber size, myofiber splitting, central nuclei, and hypercontracted myofibers. Widespread multifocal mineralizations were frequently observed. Endomysial and perimysial fibrosis was not a feature observed in axial or appendicular muscles, but was present in the diaphragm of two cats at necropsy. There was a significant decrease in the number of type 2A myofibers in dystrophin-deficient cats at both ages. Sarcolemmal dystrophin was mostly absent in all dystrophin-deficient cats; however, a small percentage of fibers stained positive, accounting for a faint residual band in the immunoblot. Carrier females had a mosaic staining pattern with irregular staining in most fibers, or even absent staining in rare fibers. However, no histological lesions were seen. Taken together, these data provide significant baseline information for further studies on the early changes associated with dystrophin deficiency in cats, or use of young dystrophin-deficient cats in therapeutic trials.
引用
收藏
页码:591 / 600
页数:9
相关论文
共 50 条
  • [41] Proteome-wide Changes in the mdx-4cv Spleen due to Pathophysiological Cross Talk with Dystrophin-Deficient Skeletal Muscle
    Dowling, Paul
    Gargan, Stephen
    Zweyer, Margit
    Henry, Michael
    Meleady, Paula
    Swandulla, Dieter
    Ohlendieck, Kay
    ISCIENCE, 2020, 23 (09)
  • [42] Normalization of nitric oxide production by dystrophin-deficient muscle reduces muscle pathology
    Wehling, M
    Spencer, MJ
    Tidball, JG
    NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) : 673 - 673
  • [43] LAMA4 and Laminin-a4 Expression in Dysferlin-Deficient versus Dystrophin-Deficient Human Skeletal Muscle
    Kang, P. B.
    Kho, A. T.
    White, A. J.
    Eisenberg, I.
    North, K. N.
    Zatz, M.
    Brown, R. H., Jr.
    Kunkel, L. M.
    ANNALS OF NEUROLOGY, 2008, 64 (06) : S148 - S148
  • [44] Increased collagen cross-linking is a signature of dystrophin-deficient muscle
    Smith, Lucas R.
    Hammers, David W.
    Sweeney, H. Lee
    Barton, Elisabeth R.
    MUSCLE & NERVE, 2016, 54 (01) : 71 - 78
  • [45] Matrix Metalloproteinase Inhibitor Batimastat Alleviates Pathology and Improves Skeletal Muscle Function in Dystrophin-Deficient mdx Mice
    Kumar, Akhilesh
    Bhatnagar, Shephali
    Kumar, Ashok
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (01): : 248 - 260
  • [46] Cytoplasmic γ-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle
    Hanft, LM
    Rybakova, IN
    Patel, JR
    Rafael-Fortney, JA
    Ervasti, JM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) : 5385 - 5390
  • [47] Carbonic anhydrase inhibitors' therapeutic effects on dystrophin-deficient mouse muscle
    Pertl, C. P.
    Segalat, L. S.
    Lochmueller, H. L.
    Thirion, C. T.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 815 - 815
  • [48] Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice
    Sandri, M
    PodhorskaOkolow, M
    Geromel, V
    Rizzi, C
    Arslan, P
    Franceschi, C
    Carraro, U
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (01): : 45 - 57
  • [49] Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness
    Marques, Maria Julia
    Machado, Rafael Ventura
    Minatel, Elaine
    Neto, Humberto Santo
    MUSCLE & NERVE, 2008, 37 (01) : 61 - 67
  • [50] EFFECTS OF CONTRACTILE ACTIVITY ON MUSCLE DAMAGE IN THE DYSTROPHIN-DEFICIENT MDX MOUSE
    MCARDLE, A
    EDWARDS, RHT
    JACKSON, MJ
    CLINICAL SCIENCE, 1991, 80 (04) : 367 - 371